Literature DB >> 23201289

Detection of Schmallenberg virus serum neutralising antibodies.

Karen L Mansfield1, S Anna La Rocca, Meenakshi Khatri, Nicholas Johnson, Falko Steinbach, Anthony R Fooks.   

Abstract

Schmallenberg virus (SBV) emerged in continental Europe in late 2011, and further work is required to assess the prevalence of SBV throughout Europe. Since its detection in Germany, SBV has now been detected in other European countries, including the United Kingdom. Infection with SBV can cause mild clinical signs in ruminants, including diarrhoea and reduced milk yield. However, the virus can have a devastating effect on the developing foetus leading to malformation in newborn offspring. This is a feature shared by other members of the Simbu group of orthobunyaviruses. Since disease in adult animals can be inapparent, serology offers the best method for monitoring for the presence of SBV and assisting in livestock management. This protocol describes a method for initial titration of SBV on African Green Monkey kidney (Vero) cells, and a plaque reduction neutralisation test (PRNT) for the detection of neutralising antibodies against SBV in cattle and sheep sera. This assay can be used to screen ruminant sera in order to confirm exposure to the virus, and the results obtained are comparable to a recently developed commercial enzyme linked immunosorbent assay (ELISA). Thus, these two assays constitute an effective diagnostic tool-box for providing confirmation of exposure to SBV. Crown
Copyright © 2012. Published by Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23201289     DOI: 10.1016/j.jviromet.2012.11.031

Source DB:  PubMed          Journal:  J Virol Methods        ISSN: 0166-0934            Impact factor:   2.014


  8 in total

1.  Generation and characterization of a potentially applicable Vero cell line constitutively expressing the Schmallenberg virus nucleocapsid protein.

Authors:  Yongning Zhang; Shaoqiang Wu; Shanshan Song; Jizhou Lv; Chunyan Feng; Xiangmei Lin
Journal:  Cytotechnology       Date:  2017-01-12       Impact factor: 2.058

Review 2.  Epidemiology, molecular virology and diagnostics of Schmallenberg virus, an emerging orthobunyavirus in Europe.

Authors:  Virginie Doceul; Estelle Lara; Corinne Sailleau; Guillaume Belbis; Jennifer Richardson; Emmanuel Bréard; Cyril Viarouge; Morgane Dominguez; Pascal Hendrikx; Didier Calavas; Alexandra Desprat; Jérôme Languille; Loïc Comtet; Philippe Pourquier; Jean-François Eléouët; Bernard Delmas; Philippe Marianneau; Damien Vitour; Stéphan Zientara
Journal:  Vet Res       Date:  2013-05-15       Impact factor: 3.683

3.  Exposure of Asian Elephants and Other Exotic Ungulates to Schmallenberg Virus.

Authors:  Fieke M Molenaar; S Anna La Rocca; Meenakshi Khatri; Javier Lopez; Falko Steinbach; Akbar Dastjerdi
Journal:  PLoS One       Date:  2015-08-14       Impact factor: 3.240

4.  Generation of recombinant Schmallenberg virus nucleocapsid protein in yeast and development of virus-specific monoclonal antibodies.

Authors:  Justas Lazutka; Aurelija Zvirbliene; Indre Dalgediene; Rasa Petraityte-Burneikiene; Aliona Spakova; Vilimas Sereika; Raimundas Lelesius; Kerstin Wernike; Martin Beer; Kestutis Sasnauskas
Journal:  J Immunol Res       Date:  2014-05-29       Impact factor: 4.818

5.  Persistence of the protective immunity and kinetics of the isotype specific antibody response against the viral nucleocapsid protein after experimental Schmallenberg virus infection of sheep.

Authors:  Antoine Poskin; Stephanie Verite; Loic Comtet; Yves Van der Stede; Brigitte Cay; Nick De Regge
Journal:  Vet Res       Date:  2015-10-15       Impact factor: 3.683

6.  Test selection for antibody detection according to the seroprevalence level of Schmallenberg virus in sheep.

Authors:  Srđan Pejaković; Laëtitia Wiggers; Damien Coupeau; Nathalie Kirschvink; James Mason; Benoît Muylkens
Journal:  PLoS One       Date:  2018-04-27       Impact factor: 3.240

7.  Immunogenicity and efficacy of Schmallenberg virus envelope glycoprotein subunit vaccines.

Authors:  Abaineh D Endalew; Bonto Faburay; Jessie D Trujillo; Natasha N Gaudreault; A Sally Davis; Vinay Shivanna; Sun Young Sunwoo; Wenjun Ma; Barbara S Drolet; D Scott McVey; Igor Morozov; William C Wilson; Juergen A Richt
Journal:  J Vet Sci       Date:  2019-11       Impact factor: 1.672

8.  High genetic variability of Schmallenberg virus M-segment leads to efficient immune escape from neutralizing antibodies.

Authors:  Kerstin Wernike; Ilona Reimann; Ashley C Banyard; Franziska Kraatz; S Anna La Rocca; Bernd Hoffmann; Sarah McGowan; Silke Hechinger; Bhudipa Choudhury; Andrea Aebischer; Falko Steinbach; Martin Beer
Journal:  PLoS Pathog       Date:  2021-01-26       Impact factor: 6.823

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.